Our Mission

PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.

Click the orange button to the right to learn more.

Category Archives for Multiple Myeloma Diagnostic Criteria

What is Stage 3 Multiple Myeloma?

What is stage 3 Multiple Myeloma? What qualifies as stage 3 MM? What are the symptoms of stage 3 MM? How worried should I be if I’ve been diagnosed with stage 3 multiple myeloma? Hi David- Within

Continue reading

Multiple Myeloma Staging- CTC

“Evaluation of CTCs in PB outperformed quantification of BM PCs. The detection of ≥ 0.01% CTCs could be a new risk factor in novel multiple myeloma staging systems for patients with transplant-eligible

Continue reading

Magnesium- Dementia

“In a study of more than 9,500 men and women, the highest or lowest levels of magnesium appeared to increase the chances for dementia by as much as 30 percent” It’s easy for researchers

Continue reading

Pediatric Cancer- Chemo-Induced Heart, Brain

“Eight of 10 pediatric cancer survivors had abnormal findings on brain, heart, and bone images, including six patients with and two patients without clinical symptoms.” Though the study linked

Continue reading

Familial Myeloma Survivor Increases Your Risk of MM

“The study published online today in Blood offers the first evidence that such familial risks exist across the spectrum of hematologic malignancies (MM).” Second only to “Why did I get

Continue reading

Myeloma, Cancer, Genetic Markers, Risk

Genetic Markers may Signal an Increased Risk of Cancer. At the Same Time Nutrition, Supplementation and Lifestyle Can Reduce your Risk of the same Cancer… I was diagnosed with multiple myeloma in

Continue reading

What African-Americans Need to Know about Myeloma

Incidence and mortality of multiple myeloma are 2-fold among Blacks than Whites…Age-adjusted incidence in African-Americans 9.5 per 100,000 per year and 4.1 per 100,00 per year in whites. While multiple

Continue reading

Chemosensitivity Testing Improves Treatment of Leukemia

“A paper in the peer-reviewed journal Leukemia & Lymphoma showed that overall survival improved 250+ percent in leukemia patients when doctors used a chemosensitivity test to help determine treatment.” As

Continue reading